From C-Suite to VC: Lessons from the Biotech Trenches

This panel of top-tier biotech CEOs turned VC investors and advisors will discuss their outlook on the financing market, and share key lessons as to how they grew and built their companies to multi-billion dollar valuations. The panel features former CEOs and C-level executives from some of the industry's largest, most prominent biotechs, who have moved to VC.